BioMedSA New Members: December 2021

BioMedSA’s Board of Directors approved 5 new memberships in Dec. 2021: Duke Law Firm, Bexar Biomedical, Loftus Management Consulting, Cell Bridge Strategies, and Southwest Texas Regional Advisory Council (STRAC). Matt Duke leads the Duke Law Firm with a focus on healthcare companies, including start-ups. He leverages his experience in multiple industries and owning technology startups … Read more

Who’s Who in SA: Jared Stein

Jared Stein is BioMedSA’s new Member and Program Manager. He is focused on engaging current and new members, supporting the growth of existing life science companies in a targeted way. Stein is a proud graduate of Texas A&M University, class of 2009. During his time at TX A&M, Stein majored in Business Management with a … Read more

Why does a Startup need a Marketing Plan Early On?

CEO:     We invented an amazing, novel, disruptive technology. The market is huge. Let’s hire a sales leader to go sell it! Sales Leader, (after a short time with the company): I thought you told me this product was ready for the market? CEO:     It is! What are you saying? Sales Leader: Our customers are upset. They’re … Read more

New Members: November 2021

BioMedSA’s Board of Directors approved 7 new memberships in November 2021: Padilla Law, Arrowhead Advisors, MercyMedical, PDS + CNC Machining, Vitanova Biomedical, Workforce Solutions and Guadalupe Bend Consulting, LLC. Padilla Law is a San Antonio based law firm that coins itself to be a “one-of-a-kind” law firm. Padilla Law specializes in a wide range of fields of law including: healthcare, business formation and structuring, start-ups, angel investors & venture capital funds, mergers & acquisitions, commercial … Read more

New BioMedSA Members: October 2021

GaitIQ is SaaS startup bringing the science of kinematics to clinical practice through low-cost and simple-to-use cloud based deep learning, data analytics, and IoT technologies. Distributed data processing, cloud computing, data analytics, artificial intelligence, deep learning, & electronic health records create a new paradigm for primary care neurodegenerative disease detection & functional monitoring. Their first … Read more

Who’s Who: Tim Anderson

Who’s Who: Tim Anderson Timothy J.C. Anderson, Ph.D., is a professor and co-lead of the Disease Intervention & Prevention Program at Texas Biomedical Research Institute (Texas Biomed). For more than 30 years, Anderson has studied how malaria and parasitic worms that cause schistosomiasis evolve to resist drugs, and how to develop better treatments that are … Read more

Who’s Who in SA: Amanda Staudt, PhD

Epidemiological studies are conducted often in San Antonio due to the diverse population. Amanda Staudt, PhD, MPH is an up-and-coming researcher conducting a study that will assess the number of healthy years lost to combat-related eye injuries. By identifying the maximum treatment time in current (shorter) timelines, Staudt proposes that treatment guidelines and expectations during prolonged field care can be informed. Her … Read more

BioMedSA Approves 100th Member

Since its founding in 2005, BioMedSA has sought key organizations to support its mission through membership. With a mission to accelerate the growth of the life science industry in the San Antonio region, and thus improve health and the economy, members know that they are supporting a movement that turns ideas into actions. Initially focused … Read more

New Members: September 2021

BioMedSA’s Board of Directors approved 8 new memberships in September 2021: CSI Health, Stephen Mcllwraith, Roger Trinh Talent Solutions, Pinnacle Clinical Research, Lisbiotech, Romph Pou Agency, Precision Group, and Grant Engine.   CSI Health provides diagnostic hardware, integrated with software for HIPAA secure data transfers and diagnostic telemedicine video conferencing. They have kiosks for health screening and diagnostics, private enclosed telemedicine clinics and mobile telemedicine solutions.  Stephen Mcllwraith is a new individual member. He is … Read more

Life Science Industry Insurance 101 from Cradle to Exit

Companies that develop and manufacture medical devices, therapeutics and pharmaceuticals are exposed to risk at each phase of development. An unexpected event can prevent the next big advancement from ever going to market. Life science executives must navigate contractual, legal and operational risk as they evolve. Here is a list of insurance coverage that is recommend at each … Read more

Login

Welcome back! Login below